Cargando…
Gonadotropin-releasing hormone type II antagonist induces apoptosis in MCF-7 and triple-negative MDA-MB-231 human breast cancer cells in vitro and in vivo
INTRODUCTION: Triple-negative breast cancer does not express estrogen and progesterone receptors, and no overexpression/amplification of the HER2-neu gene occurs. Therefore, this subtype of breast cancer lacks the benefits of specific therapies that target these receptors. Today chemotherapy is the...
Autores principales: | Gründker, Carsten, Föst, Crispin, Fister, Stefanie, Nolte, Nadine, Günthert, Andreas R, Emons, Günter |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2949636/ https://www.ncbi.nlm.nih.gov/pubmed/20630060 http://dx.doi.org/10.1186/bcr2606 |
Ejemplares similares
-
Proteomics Profiling of KAIMRC1 in Comparison to MDA-MB231 and MCF-7
por: Alghanem, Bandar, et al.
Publicado: (2020) -
Role of gonadotropin-releasing hormone (GnRH) in ovarian cancer
por: Gründker, Carsten, et al.
Publicado: (2003) -
The Role of Gonadotropin-Releasing Hormone in Cancer Cell Proliferation and Metastasis
por: Gründker, Carsten, et al.
Publicado: (2017) -
The Role of Gonadotropin-Releasing Hormone (GnRH) in Endometrial Cancer
por: Emons, Günter, et al.
Publicado: (2021) -
Role of Gonadotropin-Releasing Hormone (GnRH) in Ovarian Cancer
por: Gründker, Carsten, et al.
Publicado: (2021)